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ANTIBODY STRUCTURE AND CELLULAR 
SPECIFICITY IN THE IMMUNE RESPONSE* 
GERALD M. EDELMAN 
The Rockefeller University, New York, New York 
J. INTRODUCTION
THE idea of immunological specificity was first formulated inmolecular terms as a result of the work of Landsteiner ( 1945). 
His research on artificial hapten antigens served to ally immunology 
to chemistry and provided the operational tools necessary for the 
precise thermodynamic analysis of antigen-antibody reactions. 
From this analysis, it became clear that immunological specificity 
results from molecular complementarity between the antigenic 
determinant group and the antigen-combining site of the antibody 
molecule. Landsteiner's work was carried out on humoral anti­
bodies against a general background of belief in instructive theories 
of antibody formation. It has now become apparent, however, that 
the notion of immunological specificity must be revised and 
broadened, largely because of two developments: the clonal 
selection theory of immunity and the detailed analysis of anti­
body structure. 
In this lecture, I shall consider several ideas that have emerged 
from the structural analysis of antibodies and attempt to relate 
them� to the framework of the theory of clonal selection and
to several problems of cellular immunology at the molecular level. 
The analysis of antibodies can be considered as the first of the 
projects of molecular immunology, the task of which is to inter­
pret the properties of the immune system in terms of molecular 
structure. Before this task can be considered complete, howevei:, 
our knowledge of immunoglobulin molecules must be matched 
by a comparably detailed knowledge of the cellular and genetic 
events underlying their synthesis. Although I shall not hesitate 
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to put forth working hypotheses on these events, my main purpose 
is to consider some experimental approaches which, however in­
complete, suggest that· these events are susceptible to chemical 
and structural analysis. 
According to the theory of clonal selection (J erne, 195 5; 
Burnet, 195 9) molecular recognition of antigens occurs by selec­
tion among different lymphoid cells already committed to pro­
ducing surface antibodies prior to contact with the antigen ( Fig. 
1). Interaction of the antigen with an appropriately complemen­
tary antibody on the cell surface results in clonal expansion, i.e., 
maturation, mitosis, and increased production ·of the same kind 
of antibodies by daughter cells. 
For such a system to function effectively, there are two major 
requirements. First, a sufficient diversity of antibodies with differ­
ent combining sites must be synthesized by the cell population, 
stimulation 
Fertilized egg multiplies 
and differentiates to form 
a large number of immuno­
logically committed cells 
Clone of c_ells all making identical 
immunoglobulin 
FIG. 1. A diagram illustrating the basic features of the clonal selection theory. 
The stippling and shading indicate that different cells have antibody receptors 
of different specificities, although the specificity of all receptors on a given 
cell is the same. Stimulation by an antigen results in clonal expansion (matura­
tion, mitosis, and antibody production) of those cells having receptors comple­
mentary to the antigen. 
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each cell making surface antibodies of a single specificity that 
must, in general, be different than that of antibodies on other 
cells. Second, interaction with an antigen must either specifically 
trigger or specifically inhibit clonal expansion. Corresponding to 
these requirements are several fundamental problems of molecular 
immunology: ( 1 ) What is the origin of antibody diversity? ( 2) 
What is the mechanism of lymphocyte stimulation or suppression? 
Although these problems are far from being solved, their consid­
eration in molecular terms, particularly in terms of antibody struc­
ture, sheds new light on the nature of immunological specificity. 
JI. ANTIBODY STRUCTURE, FUNCTION, AND EVOLUTION 
Antibodies carry out two main functions in the immune re­
sponse: antigen binding functions and biologically important 
effector functions such as interaction with complement. Although 
antibodies occur in different immunoglobulin classes that mediate 
different effector functions ( Table I), within each class, the im­
munoglobulins are still enormously heterogeneous and reflect the 
diversity required for the antigen-binding function. lmmuno­
globulirts in all classes are multichain structures, consisting of 
either K or ,\ light chains and a class-distinctive heavy chain. The 
most prevalent class in mammals is IgG; detailed structural work 
indicates that molecules within this class are sufficiently represen­
tative to illustrate the basic features of the relationship between 
antibody structure and function ( for reviews, see Cold Spring 
Harbor Symposium, 1967; Nobel Symposium, 1967; Edelman 
and Gall, 1969) . 
Analysis of the complete amino acid sequence of an IgG mole­
cule ( Edelman et al., l 969) and comparison with other partial 
structures ( Cunningham et al., 1971) reveals a particularly simple 
differentiation of the structure to carry out antigen-binding and 
effector functions ( Fig. 2) . Both the light and the heavy chains 
contain variable regions consisting of the first 110-120 amino 
acid residues, having sequences that differ from molecule to mole­
cule. This observation was first made on light chains from Bence­
Jones proteins by Hilschmann and Craig ( 1965). The remaining 
portions of the chains are called constant regions because, with 
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TABLE I 
HUMAN lMMUNOGLOBULIN CLASSES 
Molecular 
weight Carbo-
(x10-3) and hydrate 
Physiological Heavy Light Molecular sedimentation content 
Class properties chain° chains formulab constant (%) 
IgG Complement fixa- 'Y Kor X ( '}'2K2) or 143-149; 6 .7 S 2.5 
tion; placental ( -y2X2) 
transfer 
IgA Localized protec- a Kor X (a2K2) or 158-162; 6.8- 5-10
tion in external (a2X2) 11.4 S 
secretions 
IgM Complement fixa- µ Kor X (µ2K2)6 or 800-950; 19. 0 S 5-10 
tion; early im- (µ2X2) 6 
mune response 
IgD Unknown 0 Kor X (02K2) or 175-180;6.6S 10 
( 02X2) 
IgE Reagin activity; Kor X (E2K2) or 185-190; 8.0 S 12 
mast cell fixation (E2A2) 
a The class distinctive features of these chains are in their constant regions. 
b IgA can have additional unrelated chains called SC and J; J chains are also 
found in IgM. For nomenclature, see W odd Health Org�nizacion, 1964. 
the exception of certain genetic polymorphisms, they are the same 
in molecules_ of a given class and subcla,ss. Experiments on the 
reconstitution of antibodies from their separate chains ( Franek 
and Nezlin, 1963; Edelman et al., 1963; Olins and Edelman, 
1964) and their completely denaturea chains ( Haber, 1964) as 
well as experiments on affinity labeling ( Singer and Doolittle, 
1966) and on the isolation of antigen-binding fragments consist­
ing of variable regions· ( Inbar et al., 1972) all indicate that both 
V H and V L regions mediate the antigen-binding function. The 
effector functions are carried out by constant regions. 
Additional hints about the evolutionary origin and functional 
differentiation of immunoglobulins have emerged from a detailed 
analysis of their primary structure ( Edelman, 1970). A considera-
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Fob(t) 
Heavy PCA"""""""""'""""',,,-------,c�".1 ------,,-.. 
chain 
Light 
chain 
NH2==--=="-------'-"-___, 
COOH COOH 
Fc(t) 
Fob (I) 
51-v -s1  s-1 --51 s -s s -s 
FIG. 2. Overall arrangement of chains and disulfide bonds of the human 
-yG1 immunoglobulin Eu. Half-cystinyl residues are 1-)�J; 1-V designate corre­
sponding half-cystinyl residues in light and heavy chains. PCA, pyrrolidonecar­
boxylic acid; CHO, carbohydrate. Fab(t) and Fc(t) refer to fragments produced 
by trypsin, which cleaves the heavy chain as indicated by dashed lines above 
half-cystinyl residues VI. Variable regions, VH and VL, are homologous. The 
constant region of the heavy chain (CH) is divided into three regions, CHI, 
CH2, and CH3, that are homologous to each other and to the C region of 
the light chain. The variable regions carry out antigen-binding functions and 
the constant region the effector functions of the molecule. 
tion of the amino acid sequences of immunoglobulin G ( Figs. 
3 and 4) supports the following conclusions: 
1. V H and V L regions are homologous to each other but are not 
obviously homologous to CH or CL regions. V regions from the 
same molecule appear to be no more closely related than V regions 
from different molecules. 
2. The constant region of the heavy chain consists of three
homology regions, CHI, CH2, and CH3, each of which is closely 
homologous to the others and to CL. 
3. Each variable region and each constant homology region
c ntains one disulfide bond, and as a result the intrachain disulfide 
bonds are linearly and periodically distributed in the structure. 
4. The region containing all the interchain disulfide bonds is·
in the middle of the linear sequence of the heavy chain and 
has no homologous counterpart in other portions of the heavy 
or the light chains. 
These observations are consistent with the hypothesis of Hill
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EU VL ( RESIDUES 1- 108) 
EU V H ( RESIDUES l - 114 ) 
l W 
ASP I LE · GLN MET THR GLN SER PRO SER THR 
PCA VAL GLN LEU VAL GLN SER GL Y - ALA 
20 30 
LEU SER ALA SER VAL Gl V ASP ARG VAL THR I LE THR CVS ARG ALA SER GLN SER I LE ASN 
GLU VAL L YS LYS PRO Gl Y SER SER VAL LYS VAL SER CVS LYS ALA SER GLY GLY THR PHE 
• 40 THR - - TRP LEU ALA TRP TYR GLN GLN LYS PRO GLY LYS ALA PRO LYS LEU LEU MET 
SER ARG SER ALA I LE I LE TR,P VAL ARG GLN ALA PRO Gl V GLN GL Y LEU GLU TRP MET GL Y 
� w 
TYR L YS ALA SER SER - LEU GLU SER GLY VAL PRO SER ARG PHE I LE GLV SER GLY SER 
GLY ILE VAL PRO MET PHE GLY PRO PRO ASN TYR ALA GLN LYS PHE GLN GLV - ARG VAL 
ro M 
GLY THR GLU PHE THR - - LEU THR I LE •SER SER LEU GLN PRO 
THR I LE THR ALA ASP GLU SER THR ASN THR ALA TYR MET GLU LEU SER SER LEU ARG SER 
90 
ASP ASP PHE ALA THR TVlt TYR CVS GLN GLN - TYR ASN SER ASP SER LYS MET PHE GLY 
GLU ASP THR ALA PHE TYR PHE CVS ALA GLY GL Y TYR GL Y I LE TYR SER PRO GLU GLU TYR 
100 
GLN GLV THR LYS VAL GLU VAL LYS GLY 
ASN GLV GLY LEU VAL THR 
FIG. 3. Comparison of the amino acid sequences of the VH and VL regions 
of protein Eu. Identical residues are shaded. Deletions indicated by dashes 
are introduced to maximize the homology. 
et al. ( 1966) and Singer and Doolittle. ( 1966) that immuno­
globulin chains arose by duplication .of a precursor gene about 
330 nucleotides in length. Because there is no clear-cut evidence 
of homology between V and C regions, however, it is somewhat 
harder to decide whether V and C regions evolved from a single 
gene. The alternative is that there were two precursor genes for 
V and C which were originally unrelated but were brought to­
gether because of the selective advantages of combining their 
functions in a single product molecule ( Edelman, 1970). 
The unusual homology relationships and arrangement of di­
sulfide bonds prompted my colleagues 3i1d me to suggest that 
the molecule is folded in a congeries of compact domains (Edel­
man, 1970; Cunningham et al., 1971), each formed by separate 
V homology regions or C homology regions ( Fig. 5). In such 
an arrangement, each domain is stabi_lized by a single intrachain 
disulfide bond and is linked to neighboring domains by less tightly 
folded stretches of the polypeptide chains. A 2-fold pseudosym-
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llO 
EU CL < RESIDUES 109-214 l THR VAL ALA I LE 
EU CHl <RESIDUES 119-220 l SER THR LYS PRO 
EU CH2 <RESIDUES 234-341) LEU LEU GLY LEU 
EU CH3 < RESIDUES 342 - 446 l GLN PRO ARG GLU PRO GLN VAi. TYR THR 
130 
ASP GI.U GLN - - LEU LYS SER GLY THR Al.A 
SER LYS SER - - THR SER GLY GI.Y 
PRO LYS ASP THR LEU MET' ILE SER ARG PRO GLU VAL-
ARG GLU GLU - - MET THR L YS ASN GLN VAL SER LEU 
140 
TVll PIIO ARG GLU ALA LYS VAL - - GLN 
PHE PRO GI.U PRO VAL THR VAL - - SER 
SER HIS GLU ASP PRO GLN VAL LYS PHE ASN 
TYR PRO SER ASP ILE ALA VAL - - GLU TRP CLU SER ASN ASP - GLY GLU GLU 
160 
ASN SER GLN GLU SER VAL THR GLU GLN ASP SER 
- VAL HIS THR PHE PRO ALA VAL LEU GLN SER -
ASN ALA LYS THR LYS PRO ARG GLU GLN GLN TYR -
ASN TYR LYS THR THR PRO PRO VAL LEU ASP SER -
180 190 
HIR LEU THR LEU SER LYS ALA ASP TYR GLU L YS HIS LYS VAL TYR ALA CVS GLU VAL THR 
VAL VAL THR VAL PRO SER SER SER LEU CLY THR CLN - THR TYR ILE CVS ASN 111M. ASN 
VAL LEU THR VAL LEU HIS GLN ASN TRP LEU ASP GLY LYS GLU TYR LYS CVS LYS VAL SER 
LYS LEU THR VAL ASP LYS SER ARC TRP GLN GLU GLY ASN VAL PHE SER CVS SER VAL MET 
200 210 
HIS GLN GLY LEU SER SER PRO VAL 'THR - LVS SER PHE -· - ASN ARC GLV GLU CYI 
HIS LYS PRO SER ASN THR LYS VAL - ,ASP LVS ARC VAL - - CLU PRO LYS SER CVS 
ASN LYS ALA LEU PRO ALA PRO I LE - CLU LYS THR I LE SER LYS ALA LYS GLY 
HIS GLU ALA LEU HIS ASN HIS TYR THR CLN LYS SER LEU SER LEU SER PRO GLY 
FIG. 4. Comparison of the amino acid sequences of CH, CHI, CH2, and CH3 
regions. Deletions, indicated by dashes, have been introduced to maximize 
homologies. Identical residues are darkly shaded; both light and dark shadings 
are used to indicate identities that occur in pairs in the same position. 
metry axis relates the VLCL to the VHCHl domains, and a true 
dyad axis through the disulfide bonds connecting the heavy chains 
relates the C .12-CH3 domains. The tertiary structure within each 
of the homologous domains is assumed to be quite similar to 
that in the others. Moreover, each domain is assumed to contribute 
to at least one active site mediating a function of the immuno­
globulin molecule. 
As I have already mentioned, the V domains have been shown 
to mediate the antigen-binding function. The proposed similarities 
in tertiary structure among C domains have not been established, 
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FIG. 5. The domain hypothesis. Diagrammatic arrangement of domains in 
the free immunoglobulin G molecule. The arrow refers to a dyad axis of 
symmetry. Homology regions ( see Figs. 2-4) which constitute each domain 
are indicated: VL, YR-domains made up of variable homology regions; CL, 
CHI, CH2, and CH3-domains made up of constant homology regions. Within 
each of these groups, ,domains are assumed to have similar three-dimensional 
structures and each is assumed to contribute to an active site. The V domain 
sites contribute to antigen recognition functions, and the C domain sites to 
effector functions. 
however, nor have the various effector functions of the different 
C domains been fully determined. There is a suggestion that CH2 
may play a role in complement fixation (Kehoe and Fougereau, 
1970). A good candidate for binding to the lymphocyte cell mem­
brane is CH3, the function of which may be concerned with the 
mechanism of lymphocyte triggering following the binding of 
antigen by V domains. The CH3 domain has already been found 
to bind to _macrophage membranes (Yasmeen et al., 1973 ). 
There is now some evidence that lymphocytes can synthesize 
isolated domains similar to CH3 ;is separate molecules. Berggard 
and Bearn ( 1968) first isolated a urinary protein called ,82-micro­
globulin from patients with renal tubular insufficiency. On the 
basis of the sequence analysis of the first 41 residues of this 
protein, Smithies and Poulik ( 1972) suggested that this protein 
was homologous to immunoglobulins. Work by Peterson et al 
( 1972) and Cunningham et al. ( 1973) in my laboratory has 
defined the complete amino acid sequence of this protein ( Fig. 
6), strongly confirming the homology. It appears, therefore, that 
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�2-M ICROGLOBUL IN ILE CLN�THR PRO LYS SER 
SER VAL PHE I LE 
SER VAL PHE PRO 
EU CL (RESIDUES 109-214) 
EU CHl (RESIDUES 119-220) 
EU CH2 (RESIDUES 234-341) 
EU CH3 (RESIDUES 342-446)
THR VAL ALA ALA PRO -
SER THR LYS GLY PRO -
LEU LEU GLY GLY PRO 
GLN PRO�GLU PRO -
20 
SER VAL 
AR G H I S PRO ALA - fciu1 -
PHE PRO PRO SER ASP�GLN 
LEU ALA PRO SER SER L YS SER 
- ASX�LYS SER ASX PHE�ASN CYS TYR§g 
- LEU LYS SER GLY THR ALA SER VAL VAL CYS LEU LEU 
- THR SER§GLY THR ALA ALA@GLY CYS LEU VAL 
PHE PRO PRO L YS PRO L YS ASP THR LEU MET I LE SER ARG THR PRO GLU VAL THR CYS VAL VAL 
LEU PRO PRO SER ARG@Ii!JGLU - - MET THR LY'S ASN GLN VAL SERmTHR CYS LEU VAL 
SER ILE 
ALA LEU 
LYS ASP TYR PHE PRO GLU PRO VAL THR VAL - SER TRP ASN SER - ALA LEU 
VAL ASP VAL SER HIS GLU ASP PRO GLN VAL LYS - VAL 
LYSIGLY(PHEITYR PRO SER ASP ILE ALA VAL - - GLU TRP GLU SER ASN ASP - - GLY 
50 60 
fGu<l LYS VALpisxl - � SER GLX LEU SER PH!c SER LYS ASN - � TRP PHE 
� SER GL Y� SER GLN GLU SER VAL THR GLU GLN ASP SER LYS ASP SER THR TYR SER LEU 
THR SER GL Y - VAL IE!] THR PHE PRO ALA VAL LEU GLN SER - � GL Y LEU TYR SER LEU 
�VAL HIS�ALA LYS THR LYS PRO ARG GLU GLN GLN TYR - ASP SER THR TYR ARG VAL 
�PRO GLU�TYR LYS THR TH R PRO PRO VAL LEU ASP SER - ASP GLY SER PHE PHE� 
70 BO 
THR GLU PHE THR PRO THR - ASP GLU TYR ALA CYS ARG VAL 
SER THR LEU THR LEU SER LYS ALA ASP TYR 
SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR GLN - THR TYR I LE CYS ASN VAL 
VAL SER VAL LEU THR VAL LEU HIS GLN ASN TRP LEU ASP GL Y LYS GLU TYR LYS CYS L YS VAL 
SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN GLN GLY ASN VAL PHE SER CYS SER VAL 
90 100 
GLX[PRo] - - - LYS ILE[§:g - �TRP ASP ARG ASP II/ET 
SER�VAL THR - LYS SER PHE - - ASN ARG GLY GLU CYS 
ASN HIS LYS PRO SER ASN THR L YS VAL - ASP L YS ARG [§:g - - GLU PRO L YS SER CYS 
SER ASN LYS ALA[LEuj PRO ALA� I LE - GLU LYS THR I LE SER0 ALA LYS GLY 
11/ET�GLU ALAWH1S ASN HIS TYR THR GLN LYS SER LEU SER LEU SER PRO GLY 
FIG. 6. Comparison of the amino acid sequence of {J,-microglobulin with 
the homology regions CL, CHl, CH2, and CH3 of the ')'G, immunoglobulin
Eu. Deletions, indicated by dashes, have been inserted to maximize homol_ogies.
Identical residues are enclosed in boxes. Numbers are for /3,-microglobulin. 
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this protein is a free immunoglobulin domain, and indeed there 
is now evidence that it is synthesized by· lymphocytes ( Bernier 
and Fanger, 1972). Even more exciting is the recent observation 
(Nakamura et al.) 1973; Peterson et al.) 1974) that this protein 
is the light polypeptide chain of the histocompatibility ( HL-A) 
antigen. This tends to support the hypothesis ( Gally and Edel­
man, 1972) that immunoglobulin genes have arisen in evolution 
from those specifying the histocompatibility system. 
Although many details still are lacking, the gross structural 
aspects of the domain hypothesis have received direct support 
from X-ray crystallographic analyses of Fab fragments (Poljak 
et al., 1972) and whole molecules (Davies et al., 1971), in which 
separate domains were clearly discerned. Indirect support for the 
hypothesis has also come from experiments on proteolytic cleavage 
of regions between domains (Gall and D'Eustachio, 1972; 
D. Inbar et al.) 1972): Whatever the selective advantages of the
domain arrangement, it is clear that gene dupliq1tion would per­
mit the modular alteration of immunological function by addition
or deletion of domains during evolution.
111. THE ORIGIN OF DIVERSITY AND THE ARRANGEMENT
OF lMMUNOGLOBULIN GENES 
On� of the most satisfying conclusions that emerged from the 
structural analysis of antibodies is that the diversity of the V 
regions of antibody chains is sufficient to satisfy the requirements 
of clonal selection theories. 
Comparis.ons of the primary structures of a great variety of 
immunoglobulins shows that the diversity of V regions has several 
distinct features. The fact that V regions fall into subgroups of 
related sequences was first pointed out for light chains by Milstein 
( 1967) and Hood et al. ( 1967) and is illustrated for heavy chains 
(Cunningham et al.) 1969; Press and Hogg, 1969; Wikler et 
al.) 1969) in Figs. 7 and 8. The sequences of the different V 
region subgroups are sufficiently different to warrant the conclu­
sion that the subgroups are specified by different genes. Within 
a subgroup, the amino acid sequence variations may be accounted 
for by single base substitutions in the genetic code. Moreover, 
EU 
HE 
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I 10 20 
�Gin ri:;;ival Gin Ser �Ala Glu Val 4'S Lys Pro Gly Ser Ser Val Lys Val Serjcysl 
�Thr�Lys Glu Asn�Pro Thr Leu Val Lys Pro Thr Glu Thr Leu Thr Leu Thr�. 
30 40 
LysAla SerGly Gly Thr PheSer ArgSer - - �Ile Ilefrrp]Val ArgGln Ala ProGly Gin Gly 
Thr Leu Ser Gly Leu Ser Leu Thr Thr Asp Gly Val �Val Glyl!!.ejlle Ar Gin Gly Pro GI Arg Ala 
50 60 70 
�Le_u_G_lu-Tr�p Met Gly Glylle Val Pro Met PheGly Pro Pro AsnTyr Alo Gin Lys PheGln Gly[A;gjVol 
Leu Glu Trp Leu Ala Trp Leu Leu Tyr Trp Asp Asp Asp Lys Arg Phe Ser Pro Ser Leu Lys Ser�Leu 
80 90 
1frhr1I1e !rhr]Alo [Asi,jG1urs;iThrfi;;jThr Alo Tyr Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Alo 
�Val l!!]Arg�Thr�Lys �Gin Vol Vol Leu Thr Met Thr Asn Met Asp Pro Vol Asp Thr Alo 
100 110 118 
Pheliir7PhefysjAlo Gly Gly Tyr Gly Ile Tyr Ser Pro - - Glu Glu Tyr As�Gly Leu[va'1Thr 
Thrhlyr �Vol His ArgHis Pro Arg Thr Leu Alo PheAspVol Trp Gly Gln�ThrLys�Ala 
FIG. 7. Comparison of VH regions of protein Eu (subgroup Vm) and protein 
He (subgroup Vm1). VH regions within each subgroup are more closely 
similar in sequence than proteins belonging to different subgroups. 
certain positions show many substitutions ( the so-called hypervari­
able regions; see Wu and Kabat, 1970) whereas others, such 
as the half-cystine residues at positions 23 and 88 of kappa chains, 
have never been observed to vary at all and may play a role 
in stabilizing the antigen combining site (Edelman, 1971). This 
set of observations indicates that both mutation and selection have 
operated to yield variable region structure. 
The ultimate origin of the mutation and selection is one of 
the two outstanding large problems of molecular immunology. 
Although this problem is not solved, it is understood that the 
diversity arises at three levels of structural or get1etic organization: 
1. Association of various V H with various V L regions; i.e.,
inasmuch as V regions from both heavy and light chains contribute 
to the antigen-binding site, the number of possible antibodies may 
be as great as the product of the number of different V L and V H 
regions (Edelman, 1971). 
160 
HE (yG) 
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I 10 
PCAVal Thr L
. 
e�Lys �
.
lulA_�n[Giy Pr;;-i:rh_rjleu Val Lys Pro ThrjGlu /Thr Leu Thr.
l �CA Val Thr LeujArg� lu Ser Gly Pro Ale Leu VofArg�ro Thr GI n Thr Leu Thr 
IPCAVol Thr[ ___ --. �· _· _  -
-
jPCAVol Thr�u]Thr�lu Ser Gly Pro Ala Leu Val Lys Pro/Lys[G1nlPro�uJ�l 
20 30 40 
[Le�h
.
r Cy; T�r G'Yl�Ser Leu!Thr T _�Asp Gly � o G
]
I 
�eu Th�s Thr Phe Ser Gly PheSer Leu Ser Gly Glu Thr\Mel Cys Vol �Trp lie Arg Gin Pro Pro Gly 
Me!Cys Vol Gly Trp Ile ArgGln Pro ProGly 
�eu Thr_ Cys Thr PheSer Gly PheSer LMSerThr]Ser Arg\;[�ijSertp !.!_e ArgfAr��r� Pro Gly 
50 60 
A 
.. 
rg Alo Le-u -Gl-u-Tr-p-Le -u-Alo Trp
t
eu Leu Ty 
.
.r fup Asp Asp AspLys�g Phe - � 
.
. 
�Pro[Ser Leu/Lys Ser 
_Glu Alo Leu Glu Trp Leu Alo Trp �jlli�eu _: A�AspAsp Lys TyrTyr - Gly A�Ser L�u c;i;;-,:;;-; 
ILys Gly Leu Glu Trp Leu Alo - Arg I le Asx Trp Asp Asp-Asp Lys Tyr Tyr - �hr Ser Leu Glu Thr 
[Lys A lo Leu Glu Trp Leu Alo 
-
A�g I le Asxf=lAsx Asx AspLystphe Tyr Trp rSer Thr Ser Leu Arg Thr 
ro oo � 
Arg Leu Thr Vol Thr ArgjA;Thr Se7i:ys Asn Gin Vol VAfeu Thr Met Thr Asn Met�A -sp_P _ro_V_o_l A-s -p
-
Th�r 
Arg Leu Alo Vol Ser Ly; Asp Thr Ser Lys AsnGln Vol Vol Leu�Met Asn Thr Vol �Pro@ly]Asp Thr 
Arg Leu Thr Ile Ser Lys Asp Thr Ser[�Asn Gin Vol Vol Leu Thr Met - - - Asp Pro Vol Asp Thr 
Arg Leu Ser Ile Ser Lys AsnAs�Ser Lys AsnGl'0'ol V-9.!_ LeJIWMet Ile �n Vol Asn Pr9 Vol Asp Thr 
100 
___ 
1_10 _____ _ 
Ala Thr Tyr Tyr Cys�ol His Arg His Pro Arg Thr Leu Alo - - - Phe Asp Vol Trp Gly Gin Gly Thr 
Alo Thr Tyr Tyr Cys A·io Arg Ser Cys Gly �Gin - - - - Tyr Phe Asp�Trp Gly Gin Gly [lie 
Alo ThrTyr Tyr CysAlo Arg Ile Thr Vol Ile Pro Alo Pro Alo Gly�sp� Trp_§_!y ��ly Th� 
Alo Thr Tyr _:Il!__C�_�j Vol Vol Asn�lvol Met 
118 
LysiVol�lo 
Leulvol Thrl 
ProlVo I ThrJ 
FIG. 8. Comparison of Vmr regions showing vanat10ns within a single 
heavy-chain subgroup. Proteins Daw and Cor are described by Press and Hogg 
(1969) and protein Ou is fromµ, chains (Wikler et al., 1969). Copyright 1969 
by the American Association for the Advancement of Science. 
2. The existence of V region subgroups, each specified by at
least one separate germ line gene which must have been selected 
during evolution (Milstein, 1967; Hood et al., 1967) . 
. 3. Intrasubgroup v<1,riation of unknown origin. 
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The key problem of the generation of antibody diversity has 
been converted by the work on immunoglobulin chains and V 
region subgroups to the problem of· the origin of sequence varia­
tions within each subgroup. It is still not known whether there 
is a germ line gene for each V region within a subgroup or 
whether each subgroup contains only a few genes, and intrasub­
group variation arises by somatic genetic rearrangements within 
precursors of antibody-forming cells. The various theories sup­
porting one or the other of these alternatives have been discussed 
elsewhere ( Gally and Edelman, 1970). At this time, therefore, 
we can conclude that only the basis, but not the ultimate origin, 
of diversity has been adequately explained by the work on 
structure. 
Although the work on the structure of antibodies has not fully 
resolved the problem of the origin of diversity, it has contributed 
much to an understanding of the nature of the structural genes 
for immunoglobulins. There is now considerable evidence to sug­
gest that the arrangement of these genes is unusual, and it may 
in fact turn out that this arrangement reflects the unusual require­
ments for the generation of diversity. Briefly, the facts leading 
to the conclusion that structural genes for immunoglobulins are 
special are as follows: whereas different V region subgroups are 
specified by a number of nonallelic genes ( Milstein, 1967) , the 
analysis of genetic or allotypic markers suggests that C regions 
of a given immunoglobulin class are specified by no more than 
one or two genes. These allotypic markers, first described by 
Grubb (1956, 1970) and Oudin (1956), provide a means in addi­
tion to sequence analysis for understanding the genetic basis of im­
munoglobulin synthesis. It has been found that V regions spe­
cified by a number of different genes can occur in different chains, 
each of which may have the same C region specified by a single 
gene. This leads to the remarkable conclusion that each immuno­
globulin chain is specified by two genes, a V gene and a C gene 
(Milstein, 1967; Hood et al., 1967). 
Work in a number of laboratories ( reviewed by Gally and 
Edelman, 1972) has shown that genetic markers on the two types 
of light chains are not linked to those of the heavy chains or 
to each other. These findings, and the conclusion that there are 
separate V and C genes, led Gally and me ( 1970, 1972) to 
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suggest that immunoglobulins are specified by three unlinked gene 
clusters ( Fig. 9). The clusters have been named translocons to 
emphasize the fact that a mechanism must be provided to combine 
genetic information from V region loci with information from 
C region loci to make complete V-C structural genes. According 
to this hypothesis, the translocon is the basic unit of immuno­
globulin evolution, different groups of immunoglobulin chains 
having arisen by duplication and various chromosomal rearrange­
ments of a precursor gene cluster. Presumably, gene duplication 
during evolution also led to the appearance of V region subgroups 
within each translocon. 
In this cursory discussion, I have attempted to show that the 
work on antibody structure carried out in a number of laboratories 
has not only satisfied certain basic requirements of the theory 
of clonal selection, but has also sharpened certain remaining ques­
tions. We now understand that the heterogeneity of antibodies 
is the result of sequence diversity of V regions as well as sequence 
differences in Ci-r region's specifying the different immunoglobulin 
classes. The structure-function problem has been neatly resolved: 
V domains carry out antigen-binding functions and C domains 
FIG. 9. A diagrammatic representation of the proposed arrangement in mam­
malian germ cells of antibody genes in three unlinked clusters termed trans­
locons. K and X chains are each specified by separate translocons, and heavy 
chains are specified by a third translocon. The exact number and arrangement 
of V and C genes within a translocon is not known. Each variable region 
subgroup ( designated by a subscript corresponding to chain group and subgroup) 
must be coded by at least one separate germ line V gene. The number of 
V genes within each subgroup is unknown, however, as is the origin of 
intrasubgroup diversity of V regions. A special event is required to link the 
information from a particular V gene to that of a given C gene. The properties 
of the classes and subclasses (see Table I) are conferred on the constant 
regions by C genes. 
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mediate effector functions. Furthermore, the evidence suggests 
that the genes for classes and domains almost certainly arose by 
gene duplication and chromosomal rearrangements during evolu­
tion. As a result of these processes, it appears that separate V 
and C genes occur in clusters, each cluster specifying a given 
kind of chain. 
Practically all these conclusions and the formulation of the 
major problem of the origin of diversity have come from work 
on humoral antibodies. This work is just a beginning, however, 
for the subject of antibodies on cells and the nature of the specific 
triggering of these cells comprise a second major problem of 
molecular immunology. Much less is known in this area of study, 
but there are some hints that it may be approached at the molecu­
lar level. 
JV. CELLULAR SPECIFICITY AND 
CELL SURFACE ANTIBODIES 
What is the mechanism by which a particular antigen induces 
clonal prolif era ti on or immune tolerance in certain populations 
of lymphoid cells? Although many means are being used by cellu­
lar immunologists to study this question, two approaches seem 
to be particularly suitable for its analysis at the molecular level. 
The first and most direct approach is to fractionate lymphocytes 
according to the specificity of their receptor antibodies both for 
subsequent studies of these antibodies and of the cellular response 
to antigens of known molecular geometry. The second approach 
is to analyze the structure and activity of molecules, such as lectins, 
that can stimulate lymphocytes regardless of their antigen-binding 
specificity. I shall discuss below some experiments, admittedly 
preliminary, that my colleagues and I have recently carried out 
using each of these approaches. 
In the attempt to understand cellular specificity, it is particularly 
important to distinguish between antigen-binding and antigen­
reactive cells ( Fig. 1 O). The work of Nossal and Makela ( see 
Makela and Cross, 1970) showed that each antibody secreting 
cell makes antibodies of a different specificity and the work of 
Ada and Nossal and others ( see Nossal and Ada, 1971) has 
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FIG. 10. A model of the somatic differentiation of antibody-producing cells 
according to the clonal selection theory. The number of immunoglobulin genes 
may increase during somatic growth so that, in the immunologically mature 
animal, differe�t lymphoid cells are formed, each committed to the synthesis 
of a structurally distinct receptor antibody ( indicated by an arabic number). 
A small proportio1_1 of these cells proliferate upon antigenic stimulation to 
form different clones of cells, each clone producing a different antibody. This 
model represents bone marrow-derived (B) cells, but with minor modifications 
it is also applicable to thymus-derived (T) cells. 
demonstrated the existence of antigen binding cells of different 
specificities. 
Inasmuch as an animal is capable of responding specifically 
to an enormous number of antigens to which it is usually never 
exposed, it must contain genetic information for synthesizing a 
much larger number of different immunoglobulin molecules on 
cells than actually appear in detectable amounts in the blood­
stream. One may therefore distinguish two levels of expression 
in the synthesis of immunoglobulins that Gally and I ( 1972) 
have termed for convenience the primotype and the clonotype 
( Fig. 10). The primotype consists of the sum total of structurally 
different immunoglobulin molecules generated within an orga­
nism during its lifetime. The clonotype consists of those immuno­
globulin molecules synthesized as a result of antigenic stimulation 
and clonal expansion. These molecules can be detected and clas­
sified according to antigen-binding specificity, class, antigenic de-
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terminants, primary structure, allotype, or a variety of other ex­
perimentally measurable molecular properties. As a class, the 
clonotype is smaller than the primotype and is wholly contained 
within it (Fig.10) . 
. Although a view of the clonotype is afforded by the analysis 
of humoral antibodies, we know very little about the primotype. 
In our laboratory, we have been attempting to approach the prob­
lem of the specific fractionation of lymphocytes expressing the 
primotype by using nylon fibers to which antigens have been 
covalently coupled (Edelman et al., 1971; Rutishauser et al., 
1972). The derivatized fibers are strung tautly in a tissue culture 
dish ( Fig. 11) so that cells shaken in suspension may collide 
with them. Some of the cells colliding with the fibers are specifi­
cally bound to the covalently coupled antigens by means of their 
surface receptors. Bound cells may be counted microscopically 
Derivatized 
� 
fiber 
� 
FIBER FRACTIONATION 
+V
j 
Specific cell binding 
l
Mechanical 
cleavage 
§+0
FIG. 11. General scheme for fiber fractionation ·of cells. Inset shows a 
tissue culture dish with nylon fibers held under tension in a polyethylene 
frame. 
166 GERALD M. EDELMAN 
in situ by focusing on the edge of the fiber ( Fig. 12). After 
washing away unbound cells, the specifically bound cells may 
be removed by plucking the fibers and shearing the cells quantita­
tively from their sites of attachment. The removed cells retain 
their viability provided that the tissue cultur� medium contains 
serum. 
Derivatized nylon fibers have the ability to bind both thymus­
derived lymphocytes ( T cells) and bone marrow-derived lympho­
cytes ( B cells) ( Gowans et a/,., 1971) according to the specificity 
a 
b 
FIG. 12. Lymphoid cells from the mouse spleen bound by their antigen-spe­
cific receptors to a nylon fiber to which dinitrophenyl bovine serum albumin 
has been coupled. Treatment of bound cells in (a) with antiserum to the 
T cell surface antigen 8 and with serum complement destroys the T cells, 
leaving B cells still viable and attached (b). See Table II. X 130. 
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of their receptors for a given antigen ( Rutishauser and Edelman, 
1972) ( Fig. 12, Table II). About 60% of spleen cells specifically 
isolated are B cells, and the remainder are T cells. By the use 
of appropriate antisera to cell surface receptors, the cells of each 
TABLE II 
CHARACTERIZATION OF MOUSE LYMPHOID CELLS 
FRACTIONATED ACCORDING TO THEIR ANTIGEN­
BINDING SPECIFICITIESa 
Antigen ,on Fiber Dnp 
N02 
�N02 
Immunization none 
Cells Bound to 
Fiber (per cm) 1200 
% Inhibition of 
Binding by: 
Dnp 90 
Tosyl I 
Anti-lg 85 
High Avidity 
Cells (per cm) <100 
Low Avidity 
Cells (per cm) 1200 
% T Cel Is 41 
% B Cells 59 
Dnp 
Dnp 
4000 
95 
2 
93 
2800 
1200 
39 
56 
Tosyl 
¢3 
To2 
none 
800 
5 
75 
73 
43 
54 
Tosyl 
Tosyl 
2000 
10 
87 
90 
0 Nylon fibers were derivatized with hapten conjugates 
of bovine serum albumin, and mice were immunized with 
each of the designated haptens coupled to hemocyanin. 
Inhibition of binding was achieved by addition of hapten­
protein conjugates (250 µg/ml) or rabbit antimouse 
immunoglobulin (lg) (250 µg/ml) to the cell suspension. 
High avidity cells are defined as those prevented from 
binding by concentrations of DNP-bovine serum albumin 
of less than 4 µg/ml in the cell suspensions. Cells inhib­
ited by higher concentrations are defined as low avidity 
cells. Virtually complete inhibition occurs at levels of 
homologous hapten greater than 100 µg/ml. 
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type can be counted on the fibers and most of the cells of one 
type or the other may then be destroyed by the subsequent addi­
tion of serum complement. In this way, one can obtain populations 
.of either T or B cells that are highly enriched in their capacity 
to bind a given antigen. 
Cells of either kind may be further fractionated according to 
the relative affinity of their receptors. This can be accomplished 
by prior addition of a chosen amount of the free antigen, which 
serves to inhibit specific attachment of subpopulations of cells 
to the antigen-derivatized fibers by binding to their receptors. 
As defined by this technique, cells capable of binding specifically 
to a particular antigen constitute as much as 1 % of a mouse 
spleen cell population. Very few of these original antigen-binding 
cells appear to increase in number after immunization, however 
(Rutishauser et al., 1972), and the cells that do respond are 
those having receptors of higher relative affinities ( Fig. 13a). 
This is in agreement with the conclusions reached by Siskind 
and Benacerraf ( 1969) in their analysis of the humoral antibody 
response. 
Using this method together with serological means of distin­
guishing T and B cells, the cells may be compared for their 
range of antigen-binding specificities and avidities for antigens. 
Our studies suggest that T and B cells do not differ in their 
antigen-binding specificities, at least for several hapten and pro­
tein antigens ( Rutishauser and Edelman, 1972) . A comparison 
of the avidities of T and B cells for the DNP hapten showed 
that the avidities of T and B cells were the same for the mono­
valent €-DNP-lysine (Fig. 13b,c). In contrast, T cells showed 
a consistently higher apparent avidity for multivalent DNP-bovine 
serum albumin containing an average of 10 DNP groups per 
molecule. This suggests the possibility that the receptors of T 
cells may be arranged or are arrangeable on the cell surface in 
clusters that differ from those of B cells. 
Whether these cell populations correspond to the cells expres­
sing the primotype remains to be determined. It is significant, 
however, that fiber-binding cells do not include plaque-forming 
cells (Jerne et al., 1963), and it is therefore possible to fractionate 
antigen-binding cells from cells that are already actively secreting 
800 
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Cells 
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10 400 
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0 
a 
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FIG. 1'3. (a) Inhibition by free DNP-BSA of spleen cell binding to DNP­
BSA derivatized fibers. Cell numbers represent fiber edge counts for a 2.5 
cm fiber segment. Spleens from immunized mice were removed at the height 
of a secondary response to DNP-BGG, and cells from several mice were 
pooled. e--e, immunized; 6.--6., unimmunized. 
( b and c) Percent inhibition of T cell ( e) and B cell ( 0) binding 
to DNP-BSA-derivatized fibers as a function of the percent inhibition of total 
cell binding. Inhibition was obtained with different amounts of (b) DNP-BSA 
or (c) E-DNP-lysine. As described (Rutishauser et al., 1972), the percent 
inhibition of total cell binding increased from O to 90% as the concentrations 
of either inhibitor increased from O to 300 µ,g/ml. T and B cells were identified 
by cytolytic treatment of the total bound cell population with anti-6 or antimouse 
immunoglobulin sera. The cells were obtained from the spleens of mice 5 
days after secondary immunization with DNP-hemocyanin. Error bars represent 
the standard deviation from the average values obtained in four experiments. 
If there were no differences in the binding behavior of T and B cells, the 
points would fall on the 45 ° line. 
antibodies. Our recent experiments indicate that the antigen-bind­
ing cells isolated by this method may be transferred to irradiated 
animals to reconstitute a response to the antigen used to isolate 
them. Moreover, they are capable of secondary immune responses 
in tissue culture. These .findings suggest that the antigen-specific 
population of cells removed from the fibers contains at least some 
of the precursors of plaque-forming cells. Although these results 
are encouraging, a number of questions remain to be answered 
concerning the specificity and function of lymphoid cells isolated 
by fiber fractionation. In addition, the method must be compared 
and combined with other means of cell fractionation. This ap­
proach should be useful for the isolation of surface antibodies 
as well as for analysis of populations of lymphoid cells in both 
developing and adult animals. 
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The comparison of the distribution of the relative affinities 
of antigen-binding cells before and after immunization ( Fig. 13a) 
suggests that the concept of immunological specificity must be 
reexamined. Diversification of receptor antibodies may to a certain 
extent have been a result of selective pressure resulting from 
exposure to certain classes of antigens during evolution. But ac­
cording to the theory of clonal selection, it is impossible for each 
cell receptor to have been selected for or against during evolution. 
Instead, a great number of antibody variants have been generated 
( by whatever process, germ line or somatic) many of which will 
never be selected during the lifetime of the organism. Under 
these circumstances how specific can such a system be? This ques­
tion can be posed in the following terms: Is the probability of 
cross-reactivity with various antigens the same in the primotype 
and the clonotype? 
The evidence on antigen-binding and antigen-reactive cells sug­
gests that the degree of cross-reactivity may be much greater in 
the primotype. If this is the case, selection for specificity cannot 
merely be the result of antigen-binding, but must also depend 
on a second factor. The most likely candidate is the triggering 
threshold for stimulation of the cell carrying the antibody recep­
tor. If, for example, a cell population contains cells that can 
bind two different antigens, specificity could be lost. It would 
be preserved, however, if a particular · cell capable of binding 
both antigens is more likely to be triggered by only one of them. 
The trigger threshold might depend on the state of the cell but 
might also depend particularly on steric factors ( reflected in the 
free energy of binding for each particular antigen) as well as 
on the surface density of the antigen molecules leading to changes 
in the avidity of the binding. 
Whatever the detailed mechanism of triggering, the implication 
of this two-factor hypothesis is that variation at the level of the 
primotype leads to a relatively nonspecific set of immunoglobulin 
molecules, many of which are capable of binding various antigens 
with relatively low specificity. According to this idea, the selective 
forces that yield specificity are a product of both the probability 
of binding and the probability of lymphocyte stimulation above 
a certain triggering threshold. 
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V. THE USE OF LECTINS FOR THE ANALYSIS OF 
LYMPHOCYTE STIMULATION 
Antigens are not the only means by which lymphocytes can 
be stimulated. It has been found that certain plant proteins called 
lectins can bind to glycoprotein receptors on the lymphocyte sur­
face and induce blast transformation, mitosis, and immunoglobu­
lin production ( see Sharon and Lis, 1972, for a review). Al­
though their mitogenic properties can be quite similar, different 
lectins have different specificities for cell surface glycoproteins as 
well as different molecular structures. In addition, they have a vari­
ety of effects on cell metabolism and transport. Such effects are in­
dependent of the antigen-binding specificity of the cell, and they 
may therefore be studied prior to specific cell fractionation. 
The fact that antigens and lectins of different specificity and 
structure may stimulate lymphocytes suggests that the induction 
of mitosis is a property of membrane-associated structures on the 
lymphocyte that can respond to a variety of receptors. The process 
of stimulation appears to be independent of the specificity of these 
receptors for their various ligands. This implies that the trig­
gering threshold may depend upon the affinity of a receptor, as 
well as upon its distribution and mode of attachment to the cell 
membrane in a given type of T or B cell. To understand mitogene­
sis, it is therefore necessary to solve two problems. The first� to 
determine in molecular detail how the lectin binds to the cell sur­
face and to compare it to the binding of antigens. The second is 
to determine how the binding induces metabolic changes necessary 
for the initiation of cell division. These changes are likely to in­
clude the production or release of a messenger which acts as a 
final common pathway for the stimulation of the cell by any par­
ticular lectin or antigen. 
In attempting to solve these problems, it would be valuable 
to know the complete structure of several different mitogenic 
lectins. This structural information is particularly useful in trying 
to understand the molecular transformation at the lymphocyte 
surface required for stimulation. With the knowledge of the 
three-dimensional structure of a lectin, for example, various amino 
acid side chains at the surface of the molecule may be modified 
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by group reagents, which also may be used to change the valence 
of the molecule. The activities of the modified lectin derivatives 
may then be observed in various assays of their effects on cell 
surfaces and cell functions. 
My colleagues and I (Edelman et al., 1972) have recently 
determined both the amino acid sequence and three-dimensional 
structure ( Fig. 14) of the lectin concanavalin A ( Con A). This 
lectin has specificity for glucopyranosides, mannopyranosides, 
and fructofuranosides, and it binds to glycoproteins and possibly 
glycolipids on a variety of cell surfaces. Our studies were aimed 
at determining the exact size and shape of the molecule, its 
valence, and the structure and distribution of its binding sites. 
With this knowledge in hand, we have been attempting to 
modify the structure and to determine the effects of that modifica­
tion on various biological activities of the lymphocyte. So far, 
there are several findings suggesting that such alterations of the 
structure have distinct effects. Con A in free solution stimulates 
thymus-derived lymphocytes (T cells) but not bone marrow-de­
rived lymphocytes ( B cells) ( Andersson et al., 1972a,b) . This 
stimulation leads to increased uptake of thymidine by the cells 
and to blast transformation. The dose response curve of stimula­
tion of T cells by native Con A shows a rising limb of thymidine 
uptake and a falling limb ( Fig. 15) that probably reflects cellular 
inhibition and death. The fact that the mitogenic effect and the 
killing effect are dose dependent suggests an analogy to stimula­
tion and tolerance induction by antigens. 
Derivatization of a lectin can alter the dose response curve. 
When Con A is succinylated, for example, it dissociates from 
a tetramer to a dimer without alteration of its carbohydrate bind­
ing specificity ( Gunther et al., 197 3). Although succinylated Con 
A is just as mitogenic as native Con A, the falling limb is not 
seen until much higher doses are reached ( Fig. 15). The dose 
response curve for this derivative indicates that the mitogenic 
response approaches saturation at high doses of the lectin. 
Succinylation of Con A also alters another effect of this lectin . 
on cell surfaces. Taylor et al. ( 1971) have demonstrated that 
immunoglobulin receptors are mobile and that they form 
"patches" and "caps" after addition of divalent antibodies 
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FIG. 1"i. Three-dimensional structure of concanavalin A, a lectin mitogenic 
for lymphocytes. (a) Schematic representation of the tetrameric structure of 
Con A viewed down the z axis. The proposed binding site for transition 
metals, calcium, and the iodine atom of the labeled inhibitor ,B-(o-iodophenyl)-D 
glucopyranoside (,B-IPG) are indicated by Mn, Ca, and I, respectively. The 
monomers on top (solid lines) are related by 2-fold axis, as are those below. 
The two dimers are paired across an axis of D, symmetry to form the tetramer. 
(b) Wire model of the polypeptide backbone of the concanavalin A monomer
oriented approximately to correspond to the monomer on the upper right 
of the diagram in (a). The two balls at the top represent the Ca and Mn
atoms and the ball in the center (marked I) is the position of an iodine 
atom in the sugar derivative, ,B-IPG, which is bound in the crystal. Four 
such monomers are joined to form the tetramer as shown in (a). ( c) A
view of the Kendrew model of the Con A monomer rotated to show the 
deep pocket formed by the binding site. (The white ball at the bottom of the 
figure is at the position of the iodine atom of ,B-iodophenyl glucoside.) The two 
white balls at the top represent the metal atoms. 
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FIG. 15. Stimulation of uptake of radioactive thymidine by mouse spleen cells 
after addition of concanavalin A ( •--•) and succinylated concanavalin 
A ( 0--0) in increasing doses ( µ,g/ ml) . 
directed against immunoglobulin receptors (Fig. 16). Yahara and 
I ( 1972) have found that, at certain concentrations, the binding 
of Con A to the cell surface restricts the movement of immuno­
globulin receptors, preventing both cap and patch formation ( Fig. 
16) . This suggests that Con A somehow changes the· fluidity
of the cell membrane, resulting in reduction of the relative mo­
bility of these receptors. In contrast, succinylated Con A has no
such effect, although it binds to lymphocytes to the same extent
as native Con A molecules and it can also compete with Con
A for binding sites.
If Con A is added to cells at 4 °C, and the cells with bound 
Con A are brought to 3 7° after washing away free Con A, the 
Con A receptors themselves will form caps. If the Con A is 
not washed away or if the experiment is carried out at 3 7 °, how­
ever, cap formation is inhibited. Succinyl-Con A does not itself 
form caps under any of these conditions nor does it inhibit cap 
formation as I have already pointed out. Even more striking is 
the observation ( Gunther et al., 197 3) that the addition of diva­
lent antibodies against Con A to cells that have already bound 
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FIG. 16. Patch and cap formation in mouse spleen cells and its inhibition 
by Con A. (a) Patterns of caps ( 1) ; patches obtained after addition of fluores­
cein-labeled antiimmunoglobulin ( 2); and diffuse distribution of fluorescence 
when cells are first treated with Con A ( 3). (b) A model for patch and 
cap formation and its inhibition by Con A. 
succinylated Con A results again in restriction of immunoglobulin 
receptor mobility. 
All these findings ( summarized in Table 3 and Fig. 17) suggest 
that Con A has two antagonistic actions that depend both on 
the state of the lectin and on the state of the cell. These actions 
are the induction of cap formation by the Con A receptors them­
selves and the inhibition of the mobility of Con A receptors 
as well as other cell receptors. The results appear to be compatible 
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FIG. 17. Schematic comparison of the biological properties of native Con 
A and succinyl-Con A. The activities listed include the immediate cellular 
reactions mediated by the lectin. 
TABLE III 
COMPARISON OF THE BIOLOGICAL ACTIVITIES OF CON A AND 
SUCCINYL-CON A 
Properties 
No. of binding sites per cell 
Sheep erythrocytes 
Mouse spleen cells 
Percent inhibition of anti-lg capping 
lectin (100 µg/ml) 
lectin (50 µg/ml) + anti-Con A (100 µg/ml) 
Percent of cells forming lectin receptor caps 
lectin (5 µg/ml, 37°) 
lectin (100 µg/ml, 37°) 
lectin (170 µg/ml), preincubated in ice bath, 
washed, then brought to 37° 
lectin (20 µg/ml) + anti-Con A (100 µg/ml) 
Mi to genesis 
lectin (5 µg/ml) 
lectin (50 µg/ml) 
Con A Succinyl-Con A 
1.1 X 106 2.8 X 106 
1.4 X 106 4.4 X 106 
100 0 
100 40 
0.2-2 0 
�0.2 0 
62 
18 82 
Positive Positive 
Negative Positive 
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with the hypothesis that there are at least two states or types 
of Con A receptors. According to this hypothesis, attachment 
of Con A to one type of receptor has no effect on the mobility 
of other receptors, but attachment to the other type inhibits the 
mobility of the other receptors. These findings may be related 
to those of Sachs and his co-workers ( M. Inbar et al., 1972) on 
the agglutination of cells by Con A. 
What is the major factor in the alteration of Con A activity 
by succinylation? The abolition of the inhibition effect in mito­
genic assays ( Fig. 15) and the failure to inhibit receptor mobility 
may be the result of a change in valence or a change in the 
surface charge of the molecule. The restoration of the Con A 
effects after addition of antibodies against Con A ( Fig. 1 7) sug­
gests that the valence is the major factor. Nonetheless, alteration 
of side chains certainly has some influence, for the acetyl deriva­
tive of Con A is also divalent at pH 7.4 and although it has 
no effect on membrane mobility, it sharply inhibits thymidine 
uptake at doses above 5 µ,g/ml (Gunther et al., 1973). Examina­
tion of other derivatives and localization of the substituted side 
chains in the three-dimensional structure should help to determine 
the exact causes of these alterations. 
In addition to modifications that lead to structures of lower 
valence, Con A may also be modified by chemically cross-linking 
several molecules. A very striking effect is seen if the surface 
density of the Con A molecules presented to the lymphocyte is 
increased by cross-linking them at solid surfaces ( Andersson et 
al., 1972a). As I have indicated, Con A in free solution stimulates 
mouse T cells, with resultant increased incorporation of radioac­
tive thymidine, but it has no effect on B cells. When cross-linked 
at a solid surface, however, it stimulates mainly mouse B cells, 
although both T and B cells have approximately the same number 
of Con A receptors. Similar results have been obtained with other 
lectins ( Greaves and Bauminger, 1972). A reasonable interpreta­
tion of these phenomena ( although not the only one) is that· 
the lectin acts at the cell surface, that the surface density of mito­
gen binding sites is an important variable in exceeding the thres­
hold for the lymphocyte stimulation, and that this threshold 
differs in the two kinds of lymphocytes. 
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VI. A WORKING HYPOTHESIS TO ACCOUNT FOR
LECTIN ACTIVITY 
Before a detailed model of lymphocyte stimulation can be for­
mulated, much more must be known about the structure and 
movements of the cell membrane and the chemistry and attach­
ment of the cell surface receptors. Nevertheless, the experiments 
that I have described and those of other workers do suggest a 
working hypothesis which may serve to consolidate the disparate 
findings on lectin activity. This working hypothesis deliberately 
excludes consideration of the important but complex mass of data 
on T cell-B cell cooperation after antigenic stimulation as well 
as the important information on nonspecific factors involved in 
the immune response ( Andersson et al., 19726). Instead, the 
hypothesis focuses on the necessary first step of mitogenesis, i.e., 
the nature and immediate consequences of lectin and antigen 
binding. 
One of the key assumptions made in formulating this hypothe­
sis is that both lectin-induced triggering and antigen-mediated 
triggering share the same mechanism as well as a final common 
pathway for surface nuclear interaction. A number of observations 
suggest that antigens and lectins stimulate lymphoid cells in the 
same way ( Greaves and Janossy, 1972) providing indirect support 
for the assumption of a shared pathway of stimulation. These 
observations include the similarity of the time course in culture, 
the indication that high doses of either lectins or antigens inhibit 
the response, and the similarity of blast formation and immuno­
globulin production. Moreover, as is the case with antigens, the 
available da.ta suggest that stimulation by lectins is mediated at 
the cell surface; suppression may be mediated at the cell surface 
but also by endocytosis of the lectin-receptor complex. Although 
T and B cells have different thresholds for stimulation and sup­
pression, it is assumed here that the same basic mechanism of 
stimulation and suppression applies to both cell types. 
The assumption that there is a common pathway of stimulation 
implies that both the mode of attachment of antibody and lectin 
receptors to the membrane and their perturbation by cross-linkage 
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at the cell surface may be similar, despite the difference in their 
specificities and molecular structures. It also implies that triggering 
or suppression of clonal prolif era ti on is specifically related to 
the mode of anchorage of the antibody molecule to the cell mem­
brane. The experiments on succinyl-Con A indicate that suppres­
sion by this lectin is related to the valence and the state of aggre­
gation of the molecule, but they do not as yet indicate whether 
these factors are important in stimulation. There are two points 
to decide: ( 1 ) Is intermolecular interaction among receptors in 
the same cell a necessary and sufficient condition for stimulation 
or is attachment to single receptors sufficient? ( 2) Are stimulation 
and suppression related or are they caused by different 
mechanisms? 
In the present hypothesis, I assume that the necessary and suffi­
cient first step in triggering is the formation of cross-linked aggre­
gates of certain of the cell surface glycoprotein receptors to form 
a micropatch. Such a micropatch would consist of as few as two 
or as many as 100 receptor molecules; after adequate stimulation, 
the membrane of a given lymphocyte could therefore have as 
many as 100-500 micropatches. These micropatches must remain 
stable ( i.e., neither increase nor decrease greatly in size) for suffi­
cient periods of time ( up to hours) and diffusion of receptors 
into and out of a micropatch must therefore be balanced. The 
formation of a micropatch requires multivalence of the antigen 
or lectin. Therefore, the formation of a micropatch of proper 
size and stability depends upon the binding constant, the valence 
of the lectin or antigen as well as upon its specificity for the 
proper cell surface receptors. Antigenic determinants or lectin 
molecules need not, however, be presented in a regular array 
to provide an adequate stimulus; the only requirement is that 
a sufficient surface density of receptor-lectin or receptor-antigen 
complexes (Fanger et al., 1970) be maintained. 
Formation of larger aggregates would lead to patches, cap for­
mation, and interruption of the stimulation cycle. Failure to form· 
micropatches rapidly enough after binding low doses of antigen 
or lectin would lead to blockade of stimulation. As I have said, 
B cells are assumed to have a different threshold of response 
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to micropatches than T cells, and it is likely that their thresholds 
for patch and cap formation also differ (Yahara and Edelman, 
unpublished observations). 
In the absence of further experimental tests of these ideas, 
little can be said in detail about the coupling of micro patch f orma­
tion to metabolic events initiating cell division. The data indicate 
that irreversible changes in vitro require as long as 12-24 hours 
of exposure to lectins, and it is likely that a whole series of 
enzymatic reactions are involved. The assumption that there is 
a final common pathway for the mitogenic stimulus, however, 
would suggest a single mediator such as cyclic AMP or cyclic 
GMP, and there is some evidence that the latter is involved 
( Hadden et al., 1972). A possible means of coupling micropatch 
formation to metabolic changes is via interaction with enzymes 
such as adenyl cyclase or phosphodiesterase. One plausible hy­
pothesis is that the formation of stable micropatches allows inter­
action of intramembranous particles to which such enzymes might 
be linked. Such interactions could result in induction of enzymatic 
action via allosteric or other conformational changes. An alterna­
tive mode in which receptor aggregation may be coupled to meta­
bolic events is by means of transport defects, induced after pertur­
bation of the alignment of the phospholipid head groups by the 
micropatches in the membrane. Movements of ions or small mole­
cules in or out of the cell might then provide the necessary stimu­
lus. Finally, lectin effects may be indirect and require the induc­
tion in one cell type of stimulatory or inhibitory factors, which 
then act on target cells, i.e., two cell types may be required 
(Andersson.et al. 1 19726). 
The foregoing hypothesis on the necessary initial conditions 
for stimulation and suppression is compatible with any one of 
these subsequent metabolic events and it leads to a number of 
predictions: ( 1) the valence, state of aggregation, specificity, and 
binding constant for carbohydrate on the appropriate receptors 
are overriding in stimulation; the detailed structure of a particular 
mitogenic lectin plays only a minor role in mitogenic activity. 
Only certain cell receptors are linked to the mitogenic pathway; 
some lectins will be nonmitogenic because they bind to receptors 
that are not so linked. ( 2) If lectins that are multivalent are 
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made univalent, mitogenesis will be blocked ( an exception to 
this prediction might conceivably occur if univalent lectins aggre­
gated after binding to the cell surface) . ( 3) Lectins that are 
not mitogenic for B cells but are mitogenic for T cells may be 
made mitogenic for B cells by cross-linking ( this has already 
received support in two cases, as I have already indicated). ( 4) 
Some lectins that are not mitogenic may become mitogenic by 
cross-linking them to themselves or to other lectins, or after cou­
pling them to Fab fragments of anti-immunoglobulins. ( 5) In 
a purified cell population specific for binding to a given antigen, 
stimulation by an antigen in the proper form should be additive 
with stimulation by a mitogenic lectin. 
Now that fractionated populations of lymphocytes specific for 
particular antigens are available, it should be possible to determine 
the connection between lectin-induced and antigen-induced 
changes by comparing responses to molecular variants of both 
agents on the same cells and to test various hypotheses on the 
mechanisms of lymphocyte stimulation. Ultimately, of course, we 
must return to the cell surface antibody itself and relate its mode 
of attachment and function at the cell surface to our knowledge 
of antibody structure. 
VII. CONCLUSION 
Our understanding of the origin of immunoglobulin diversity 
and of the molecular mechanisms of lymphocyte stimulation is 
in a very early stage. Experiments stemming from the analysis 
of antibody structure suggest, however, that these two outstanding 
problems of immunology can be profitably attacked at a molecular 
level. The results of the experiments on antibody structure provide 
a basis for studying antibodies on lymphoid cells as well as a 
molecular framework for the understanding of cellular specificity 
in the immune response. It appears that immunological specificity 
results from the interaction of a number of factors including 
the specificity of the initial binding of the antigen, the affinity 
and avidity of the antibody receptors and the cellular threshold 
for stimulation and clonal expansion. In order to understand this 
interaction in detail, it is necessary to study the structure of the 
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lymphoid cell membrane and particularly the mode of attachment 
of its antibody and lectin receptors. Recent developments in the 
specific fractionation of lymphocytes and in the analysis of the 
structure and function of membrane probes such as lectins should 
help to ease this task. 
A fuller understanding of the behavior and specificity of 
lymphocyte receptors and the mechanism of mitogenesis may not 
only help to solve one of the central problems of immunology, 
but also be of great importance for a general understanding of 
growth control and cellular interactions in other areas of cell 
biology. The pace of recent developments both in this field and 
in molecular immunology suggests that we can look forward to 
an exciting decade of research. 
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